dabigatran has been researched along with Liver Failure, Acute in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guglielmo, N; Mestroni, R; Montanari, G; Orso, D | 1 |
| Bardou, M; Billionnet, C; Drouin, J; Maura, G; Neumann, A; Weill, A | 1 |
| Munasinghe, A; Rao, V | 1 |
3 other study(ies) available for dabigatran and Liver Failure, Acute
| Article | Year |
|---|---|
A Case of Liver Failure Due to Dabigatran Treated with Venovenous Hemodiafiltration and Idarucizumab.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antithrombins; Chemical and Drug Induced Liver Injury; Continuous Renal Replacement Therapy; Dabigatran; Humans; Liver Failure, Acute; Male | 2020 |
Oral anticoagulants and risk of acute liver injury in patients with nonvalvular atrial fibrillation: a propensity-weighted nationwide cohort study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alcoholism; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Female; France; Humans; Liver Failure, Acute; Male; Middle Aged; Propensity Score; Proportional Hazards Models; Pyrazoles; Pyridones; Risk; Rivaroxaban; Young Adult | 2020 |
Acute liver failure after changing oral anticoagulant from apixaban to rivaroxaban.
Topics: Administration, Oral; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Humans; Liver Failure, Acute; Male; Pyrazoles; Pyridones; Rivaroxaban | 2021 |